Pancreatic Cancer Research

ResearcherUniversity Health NetworkActive in the last 2 years

Lillian Siu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-3500-0540; OpenAlex author ID A5000204204. Sources: ClinicalTrials.gov.

Their work

Papers
3
Trials
4 (principal investigator on 4)
Grants
0
Labs led
0
Collaborators
19
Papers, trials and grants by year

2013: 1 trial · 2014: none · 2015: none · 2016: none · 2017: none · 2018: none · 2019: 1 trial · 2020: 1 paper · 2021: 1 trial · 2022: 1 paper, 1 trial · 2023: none · 2024: 1 paper

Papers 3

  1. A Phase II, Open-Label, Randomized Trial of Durvalumab With Olaparib or Cediranib in Patients With Mismatch Repair-Proficient Colorectal or Pancreatic Cancer. Co-author DOI 10.1016/j.clcc.2024.05.002↗
  2. A phase II trial of GSK2256098 and trametinib in patients with advanced pancreatic ductal adenocarcinoma. Co-author DOI 10.21037/jgo-22-86↗
  3. A Phase I Study of Dinaciclib in Combination With MK-2206 in Patients With Advanced Pancreatic Cancer. Co-author DOI 10.1111/cts.12802↗

Trials 4

  1. Marathon of Hope Cancer Centres Network Study for Ontario (MOHCCN-O) Principal investigator NCT05403177↗
  2. A Multi-Cancer, Multi-State, Platform Study of Durvalumab (MEDI4736) and Oleclumab (MEDI9447) in Pancreatic Adenocarcinoma, Non-Small Cell Lung Cancer and Squa… Principal investigator NCT04262388↗
  3. Study of DNA Damage, Angiogenesis, and PD-L1 Inhibitors in Advanced Solid Tumors Principal investigator NCT03851614↗
  4. Prospective Comprehensive Molecular Profiling In Neuroendocrine Tumors Principal investigator NCT02586844↗

Closest collaborators

The 19 strongest of 19 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Philippe Lucien Bedard · 2 shared papers, 2022–2024 · strength 0.27
  2. Aaron Richard Hansen · 2 shared papers, 2020–2024 · strength 0.25
  3. María Vila-Casadesús · 1 shared paper, 2024 · strength 0.16
  4. Alberto Hernando‐Calvo · 1 shared paper, 2024 · strength 0.16
  5. Benjamin Haibe‐Kains · 1 shared paper, 2024 · strength 0.16
  6. Ana P. Vivancos · 1 shared paper, 2024 · strength 0.16
  7. David William Hedley · 1 shared paper, 2022 · strength 0.12
  8. Sandra Elisabeth Fischer · 1 shared paper, 2022 · strength 0.12
  9. Rachel Anne Goodwin · 1 shared paper, 2022 · strength 0.12
  10. Neesha C. Dhani · 1 shared paper, 2022 · strength 0.12
  11. Jennifer Jane Knox · 1 shared paper, 2022 · strength 0.12
  12. Steve Gallinger · 1 shared paper, 2022 · strength 0.12
  13. Kyaw Lwin Aung · 1 shared paper, 2022 · strength 0.12
  14. Barry D. Nelkin · 1 shared paper, 2020 · strength 0.09
  15. Noelle K. LoConte · 1 shared paper, 2020 · strength 0.09
  16. Adrian Gerard Murphy · 1 shared paper, 2020 · strength 0.09
  17. Nilofer Saba Azad · 1 shared paper, 2020 · strength 0.09
  18. Anirban Maitra · 1 shared paper, 2020 · strength 0.09
  19. Colin D. Weekes · 1 shared paper, 2020 · strength 0.09

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.